human immunodeficiency (O-antigen) antibody and antigen (Recombinant protein)
Diagnostic immunodeficiency virus-O antigen (HIV-O) antibodies (anti-human immunodeficiency, anti-O-antigen) and antigens (recombinant immunodeficiency virus-O antigen (HIV-O) protein) for Infectious disease O-antigen detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-IVD-P006-Tg001-Ag01 | Recombinant human immunodeficiency virus-O antigen (HIV-O) O-antigen Protein | 3090 |
GMP-IVD-P006-Tg001-Ab01 | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P006-Tg001-Ab02 | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) | 1953 |
GMP-IVD-P006-Tg001-Ab03 | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb) | 1953 |
GMP-IVD-P006-Tg001-Ab04 | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-IVD-P006-Tg001-Ag01 |
Product Name | Recombinant human immunodeficiency virus-O antigen (HIV-O) O-antigen Protein |
Pathogen | immunodeficiency virus-O antigen |
Target/Biomarker | O-antigen |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | O-antigen (O-antigen) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human immunodeficiency virus-O antigen (HIV-O) O-antigen Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P006-Tg001-Ab01, GMP-IVD-P006-Tg001-Ab02 |
Product Name | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) |
Pathogen | immunodeficiency virus-O antigen |
Target/Biomarker | O-antigen |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | O-antigen (O-antigen) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P006-Tg001-Ab03, GMP-IVD-P006-Tg001-Ab04 |
Product Name | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb) |
Pathogen | immunodeficiency virus-O antigen |
Target/Biomarker | O-antigen |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | O-antigen (O-antigen) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in O-antigen level test of Infectious disease (AIDS) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human immunodeficiency virus-O antigen (HIV-O) O-antigen human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
The immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes the acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments